Figure 9.The candidate compounds targeting HRS. (A) The volcano plot displayed the DEGs between low-HRS and high-HRS cases. (B–I) Seven compounds, including cephaeline (C), LY-294002 (D), lycorine (E), naltrexone (F), nefopam (G), tanespimycin (H), and wortmannin (I), were identified.
